Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: The Austrian experience

World Journal of Urology

Volumn 31, Issue 1, 2013, Pages 37-44

  Fajkovic, Harun ^a   Klatte, Tobias ^b   Nagele, Udo ^c   Dunzinger, Michael ^c   Zigeuner, Richard ^d   Hübner, Wilhelm ^c   Remzi, Mesut ^c  

^a Karl Landsteiner Institute for Implementation of Innovative Techniques in Cardiac Surgery   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Landeskrankenhaus Hall in Tirol ^*  (Austria)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Conservative treatment; Endoscopic treatment; Laser ablation; Percutaneous treatment; Upper tract; Upper tract urothelial cell carcinoma; Upper urinary tract carcinoma; Ureteroscopic management; Urothelial carcinoma; UTUC

Indexed keywords

EID: 84873123987     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0948-4     Document Type: Article

References (53)

1. Munoz JJ, Ellison LM (2000) Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164(5): 1523-1525.
2. Rouprêt M, Zigeuner R, Palou J, Boehle A, Kaasinen E, Sylvester R, Babjuk M, Oosterlinck W (2011) European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59(4): 584-594.
3. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG, Collaboration UTUCCUTUC (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115(6): 1224-1233.
4. Kaag MG, O'Malley RL, O'Malley P et al (2010) Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. Eur Urol 58(4): 581-587.
5. Zhang QL, Rothenbacher D (2008) "Prevalence of chronic kidney disease in population-based studies: systematic review". BMC public health 8: 117.
6. USRDS (2010) United States Renal Data System 2010 Annual Data Report. Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD http://www. usrds. org/2010/pdf/v1_04. pdf.
7. Cutress ML, Stewart GD, Wells-Cole S, Phipps S, Thomas BG, Tolley DA (2012) Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int. doi: 10. 1111/j. 1464-410X. 2012. 11169. x.
8. Grasso M, Fishman AI, Cohen J, Alexander B (2012) Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int doi. doi: 10. 1111/j. 1464-410X. 2012. 11066. x.
9. Gadzinski AJ, Roberts WW, Faerber GJ, Wolf JS (2010) Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J Urol 183(6): 2148-2153.
10. Cornu JN, Rouprêt M, Carpentier X, Geavlete B, de Medina SG, Cussenot O, Traxer O (2010) Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J Urol 28(2): 151-156.
11. Pak RW, Moskowitz EJ, Bagley DH (2009) What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. J Endourol 23(3): 341-346.
12. Lucas SM, Svatek RS, Olgin G, Arriaga Y, Kabbani W, Sagalowsky AI, Lotan Y (2008) Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int 102: 172-176.
13. Painter DJ, Denton K, Timoney AG, Keeley FX (2008) Ureteroscopic management of upper-tract urothelial cancer: an exciting nephron-sparing option or an unacceptable risk? J Endourol 22(6): 1237-1239.
14. Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Segura JW, Zincke H, Elliott DS, Blute ML (2007) Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma. J Urol 177(5): 1721-1726.
15. Reisiger K, Hruby G, Clayman and Landman RV, Landman J (2007) Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome. Urology 70: 263-266.
16. Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O (2006) Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67(6): 1181-1187.
17. Johnson GB, Fraiman M, Grasso M (2005) Broadening experience with the retrograde endoscopic management of upper urinary tract urothelial malignancies. B JU Int 95(Suppl. 2): 110-113.
18. Iborra I, Solsona E, Casanova J, Ricós JV, Rubio J, Climent MA (2003) Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression. J Urol 169(1): 82-85.
19. Matsuoka K, Lida S, Tomiyasu K, Inoue M, Noda S (2003) Transurethral endoscopic treatment of upper urinary tract tumors using a holmium: YAG laser. Lasers Surg Med 32: 336-340.
20. Daneshmand S, Quek ML, Huffman JL (2003) Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer 98: 55-60.
21. Engelmyer EI, Belis JA (1996) Long-term ureteroscopic management of low-grade transitional cell carcinoma of the upper urinary tract. Tech Urol 2(2): 113-116.
22. Gaboardi F, Bozzola A, Dotti E, Galli L (1994) Conservative treatment of upper urinary tract tumors with Nd: YAG laser. J Endourol 8: 37-41.
23. Andersen JR, Kristensen JK (1994) Ureteroscopic management of transitional cell tumors. Scand J Urol Nephrol 28: 153-157.
24. Schmeller NT, Hofstetter AG (1989) Laser treatment of ureteral tumors. J Urol 141(4): 840-843.
25. Wolf SJ Jr (2009) Are we underutilizing minimally invasive approaches for upper tract urothelial carcinoma? Urol Oncol 27(1): 75-80.
26. Remzi M, Haitel A, Margulis V et al (2009) Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103(3): 307-311.
27. Tavora F, Fajardo DA, Lee TK, Lotan T, Miller JS, Miyamoto H, Epstein JI (2009) Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am J Surg Pathol 33(10): 1540-1546.
28. Roupret M, Traxer O, Tligui M et al (2007) Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur Urol 51: 709-714.
29. Rink M, Fajkovic H, Cha EK, Gupta A, Karakiewicz PI, Chun FK, Lotan Y, Shariat SF (2012) Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol 61(4): 854-855.
30. Rastinehad AR, Ost MC, Vanderbrink BA, Greenberg KL, El-Hakim A, Marcovich R, Badlani GH, Smith AD (2009) A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy? Urology 73(1): 27-31.
31. Palou J, Caparrós J, Orsola A, Xavier B, Vicente J (1995) Transurethral resection of the intramural ureter as the first step of nephroureterectomy. J Urol 154(1): 43-44.
32. Goel MC, Mahendra V, Roberts JG (2003) Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol 169(3): 925-929; discussion 929-930.
33. Clark PE, Streem SB, Geisinger MA (1999) 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J Urol 161(3): 772-775; discussion 775-776.
34. Patel A, Soonawalla P, Shepherd SF, Dearnaley DP, Kellett MJ, Woodhouse CR (1996) Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J Urol 155: 868-874.
35. Plancke HR, Strijbos WE, Delaere KP (1995) Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis. Br J Urol 75: 736-739.
36. Fuglsig S, Krarup T (1995) Percutaneous nephroscopic resection of renal pelvic tumors. Scand J Urol Nephrol 172: 15-17.
37. Tasca A, Zattoni F, Garbeglio A, Villi G, Bassi P, Meneghini A (1992) Endourologic treatment of transitional cell carcinoma of the upper urinary tract. J Endourol 6: 253-256.
38. Raymundo EM, Lipkin ME, Bañez LB, Mancini JG, Zilberman DE, Preminger GM, Inman BA (2011) Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. J Endourol 25(3): 377-384.
39. Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML (2008) Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract. BJU Int 102(9): 1107-1110.
40. Suh RS, Faerber GJ, Wolf JS (2003) Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J Urol 170(6 Pt 1): 2209-2216.
41. Deligne E, Colombel M, Badet L, Taniere P, Rouviere O, Dubernard JM, Lezrek M, Gelet A, Martin X (2002) Conservative management of upper urinary tract tumors. Eur Urol 42(1): 43-48.
42. Martínez-Piñeiro JA, García Matres MJ, Martínez-Piñeiro L (1996) Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J Urol 156(2 Pt 1): 377-385.
43. Bagley DH, Grasso M (2010) Ureteroscopic laser treatment of upper urinary tract neoplasms. World J Urol 28: 143-149.
44. Remzi M, Shariat S, Huebner W, Fajkovic H, Seitz C (2011) Upper urinary tract urothelial carcinoma: what have we learned in the last 4 years? Ther Adv Urol 3(2): 69-80.
45. Remzi M, Javadli E, Özsoy M (2010) Management of small renal masses: a review. World J Urol 28(3): 275-281.
46. Jeldres C, Lughezzani G, Sun M, Isbarn H, Shariat SF, Budäus L, Lattouf JB, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz P (2010) Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J Urol 183(4): 1324-1329.
47. Chen GL, Bagley DH (2000) Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 164: 1173-1176.
48. Brown GA, Matin SF, Busby JE et al (2007) Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology. 70: 252-256.
49. Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH (2012) High Rate of Pathologic Upgrading at Nephroureterectomy for upper tract urothelial carcinoma. Urology 79: 615-619.
50. Cutress MLl, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA (2012) Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. doi: 10. 1111/j. 1464-410X. 2012. 11068. x.
51. Weizer AZ, Faerber GJ, Wolf JS Jr (2007) Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. Urology 70(3): 469-472.
52. Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD et al (2012) Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. doi: 10. 1016/j. eururo. 2012. 04. 052.
53. O'Brien T, Ray E, Singh R, Coker B, Beard R (2011) Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 60(4): 703-710.